IBD Therapeutics Incubator
Funds long-term academic-industry collaborations to advance new inflammatory bowel disease treatment targets.
About
The IBD Therapeutics Incubator is the Crohn's & Colitis Foundation's collaborative drug-discovery route for Crohn's disease and ulcerative colitis. It pairs academic researchers with a specialized CRO and the Foundation's drug discovery staff to advance novel or validated drug targets into therapeutic products.
Awards can reach $1.5 million over three years, and most of the budget is directed to …
Max award$1.5M
Realistic median-
Success rate-
Decision time-
No upcoming rounds verified. Cadence: Rolling.